Biotechnology
33 total deals across 21 companies.
Latest Funding
Company
Location
Latest Round
Amount
Date
BioLamina
Sundbyberg, Sweden
—
Debt Financing
$20.0M
Apr 17, 2026
ONWARD Medical
Eindhoven, Netherlands
—
Growth
$40.6M
Apr 17, 2026
Standing Ovation
Paris, France
—
Series B
$32.4M
Mar 31, 2026
Gilgamesh Pharma
United States
—
Series A
$60.0M
Mar 24, 2026
Crossbow Therapeutics
United States
—
Series B
$77.0M
Mar 18, 2026
R1 Therapeutics
Toa Baja, United States
—
Series A
$77.5M
Mar 17, 2026
Prolium Bioscience
United States
—
Series A
$50.0M
Mar 3, 2026
BreezeBio
South San Francisco, United States
—
Series B
$60.0M
Feb 25, 2026
Slate Medicines
Raleigh, United States
—
Series A
$130.0M
Feb 24, 2026
QT Sense
Groningen, Netherlands
—
Seed
$4.8M
Feb 4, 2026
Octarine Bio
Copenhagen, Denmark
—
Series A
$15.0M
Jan 23, 2026
Nordic Bioproducts Group
Turku, Finland
—
Strategic
Undisclosed
Jan 21, 2026
Exciva
London, United Kingdom
—
Series B
$59.0M
Jan 20, 2026
Converge Bio
Boston, United States
—
Series A
$25.0M
Jan 15, 2026
Caldera Therapeutics
Cambridge, United States
—
Series A
$37.5M
Jan 14, 2026
SynthBio Labs
Singapore, Singapore
—
Series A
$35.0M
Jan 10, 2026
Diagonal Therapeutics
Cambridge, United States
—
Series B
$125.0M
Jan 8, 2026
EpiBiologics
San Francisco, United States
—
Series B
$107.0M
Jan 8, 2026
Boltz
Cambridge, United States
—
Seed
$28.0M
Jan 7, 2026
BlueNalu
San Diego, United States
—
Angel
$11.0M
Jan 2, 2026
Solugen
Houston, TX, United States
—
Series C
$60.0M
Feb 1, 2022